These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
240 related articles for article (PubMed ID: 20166959)
1. Neuronal nicotinic acetylcholine receptors - targets for the development of drugs to treat cognitive impairment associated with schizophrenia and Alzheimer's disease. Haydar SN; Dunlop J Curr Top Med Chem; 2010; 10(2):144-52. PubMed ID: 20166959 [TBL] [Abstract][Full Text] [Related]
2. The wonderland of neuronal nicotinic acetylcholine receptors. Bertrand D; Terry AV Biochem Pharmacol; 2018 May; 151():214-225. PubMed ID: 29248596 [TBL] [Abstract][Full Text] [Related]
3. The α7 nAChR selective agonists as drug candidates for Alzheimer's disease. Fan H; Gu R; Wei D Adv Exp Med Biol; 2015; 827():353-65. PubMed ID: 25387975 [TBL] [Abstract][Full Text] [Related]
4. Advances in the In vitro and In vivo pharmacology of Alpha4beta2 nicotinic receptor positive allosteric modulators. Wilkerson JL; Deba F; Crowley ML; Hamouda AK; McMahon LR Neuropharmacology; 2020 May; 168():108008. PubMed ID: 32113032 [TBL] [Abstract][Full Text] [Related]
12. Nicotinic system involvement in Alzheimer's and Parkinson's diseases. Implications for therapeutics. Newhouse PA; Potter A; Levin ED Drugs Aging; 1997 Sep; 11(3):206-28. PubMed ID: 9303280 [TBL] [Abstract][Full Text] [Related]
13. Activators of α7 nAChR as Potential Therapeutics for Cognitive Impairment. Wang X; Bell IM; Uslaner JM Curr Top Behav Neurosci; 2020; 45():209-245. PubMed ID: 32451955 [TBL] [Abstract][Full Text] [Related]
14. Targeting the nicotinic alpha7 acetylcholine receptor to enhance cognition in disease. Wallace TL; Porter RH Biochem Pharmacol; 2011 Oct; 82(8):891-903. PubMed ID: 21741954 [TBL] [Abstract][Full Text] [Related]
15. Discovery of a novel alpha-7 nicotinic acetylcholine receptor agonist series and characterization of the potent, selective, and orally efficacious agonist 5-(4-acetyl[1,4]diazepan-1-yl)pentanoic acid [5-(4-methoxyphenyl)-1H-pyrazol-3-yl] amide (SEN15924, WAY-361789). Zanaletti R; Bettinetti L; Castaldo C; Cocconcelli G; Comery T; Dunlop J; Gaviraghi G; Ghiron C; Haydar SN; Jow F; Maccari L; Micco I; Nencini A; Scali C; Turlizzi E; Valacchi M J Med Chem; 2012 May; 55(10):4806-23. PubMed ID: 22468936 [TBL] [Abstract][Full Text] [Related]
16. Nicotine binding in human striatum: elevation in schizophrenia and reductions in dementia with Lewy bodies, Parkinson's disease and Alzheimer's disease and in relation to neuroleptic medication. Court JA; Piggott MA; Lloyd S; Cookson N; Ballard CG; McKeith IG; Perry RH; Perry EK Neuroscience; 2000; 98(1):79-87. PubMed ID: 10858614 [TBL] [Abstract][Full Text] [Related]
17. A cog in cognition: how the alpha 7 nicotinic acetylcholine receptor is geared towards improving cognitive deficits. Leiser SC; Bowlby MR; Comery TA; Dunlop J Pharmacol Ther; 2009 Jun; 122(3):302-11. PubMed ID: 19351547 [TBL] [Abstract][Full Text] [Related]
18. Nicotinic acetylcholine receptors as drug targets. Hogg RC; Bertrand D Curr Drug Targets CNS Neurol Disord; 2004 Apr; 3(2):123-30. PubMed ID: 15078187 [TBL] [Abstract][Full Text] [Related]